According to regulatory filings released to the Australian Securities Exchange (ASX) and New Zealand’s Exchange (NZX), the board considered it standard practice for executives to sell up to half of their vested equity to settle statutory tax liabilities. Following the vesting events and subsequent tax-related disposals, executive shareholdings across the senior leadership group remain substantially above required minimum shareholding guidelines, with Managing Director and CEO David Bortolussi holding equity valued at more than six times his mandatory executive threshold.

In contrast to executive tax sales, several independent non-executive directors have actively increased their direct stakes through on-market share purchases. Disclosures show director Grant Dempsey acquired an initial stake of 70,000 shares, while fellow independent directors Lain Jager and Pei-yu (Sandra) Yu expanded their respective shareholdings through open-market transactions, signaling continued board-level alignment with long-term strategy.

The insider trading updates follow a2 Milk’s full-year earnings disclosures, which reflected continued resilience across its core infant nutrition and liquid milk business lines despite demographic headwinds in Greater China. While China’s lower birth rates continue to constrain broader formula volume growth, a2 Milk has defended its premium market share in Chinese mother-and-baby store networks while expanding distribution into cross-border e-commerce channels and adjacent adult functional dairy powders.